Progestogens and target tissues: Vascular systems

This publication has 86 references indexed in Scilit:

• Do the cardiovascular disease risks and benefits of oral versus transdermal estrogen therapy differ between perimenopausal and postmenopausal women?
  Menopause, 2007
• Drospirenone with 17β-estradiol in the postmenopausal woman with hypertension
  Climacteric, 2007
• Effect of Transdermal Hormone Replacement Therapy on the Monocyte Chemoattractant Protein-1 Concentrations and Other Vascular Inflammatory Markers and on Endothelial Function in Postmenopausal Women
  The American Journal of Cardiology, 2005
• C-Reactive Protein: Risk Marker or Mediator in Atherothrombosis?
  Hypertension, 2004
• Effects of Conjugated Equine Estrogen in Postmenopausal Women With Hysterectomy
  JAMA, 2004
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Progesterone and 17 β-estradiol acutely stimulate nitric oxide synthase activity in rat aorta and inhibit platelet aggregation
  Life Sciences, 2001
• The Long-Term Effects of Oral and Transdermal Postmenopausal Hormone Replacement Therapy on Nitric Oxide, Endothelin-1, Prostacyclin, and Thromboxane
  Fertility and Sterility, 1998
• Circulating Nitric Oxide (Nitrite/Nitrate) Levels in Postmenopausal Women Substituted With 17β-Estradiol and Norethisterone Acetate
  Hypertension, 1995
• Pharmacodynamic profile of prostacyclin
  The American Journal of Cardiology, 1995